View Financial HealthCochlear 配当と自社株買い配当金 基準チェック /36Cochlear配当を支払う会社であり、現在の利回りは3.49%で、収益によって十分にカバーされています。主要情報3.5%配当利回り0.1%バイバック利回り総株主利回り3.6%将来の配当利回り3.5%配当成長6.0%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向81%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jul 13Cochlear Limited Announces FDA Clearance of The Osia 3 Sound ProcessorCochlear Limited received FDA clearance of the new Cochlear Osia 3 Sound Processor, the newest advancement of the Osia System. The Osia 3 Sound Processor is the first fully rechargeable active bone conduction sound processor, with up to 30 hours of battery life on a single charge. It features an on-the-go charging case that holds additional charges, similar to wireless earbuds. The Osia 3 Sound Processor offers improved clarity and sound quality, enhanced by the new signal processing platform and powerful lithium-ion battery. It now has a fitting range up to 65 dB HL bone conduction thresholds in the mid to high frequencies. The new Zaphium signal processing chip offers a wider frequency bandwidth than the previous generation and includes ForwardFocus technology, to help patients filter out the clutter of noise and focus on what matters. The Osia 3 Sound Processor joins Cochlear's industry-leading connectivity with streaming from Android, Apple, Bluetooth LE Audio and Auracast broadcast audio sources. Auracast broadcast audio allows patients to share music with a friend or tune into shared audio in places like cinemas, concert venues, lecture halls and airports, as more devices and venues adopt the technology. The Osia 3 Sound Processor is compatible with Remote Care, wireless fitting capability and improved data logging support for more convenient and intuitive fittings. With backwards compatibility, current Osia System patients who are eligible can benefit from upgrading to the Osia 3 Sound Processor no matter which Osia Implant model they have. The Osia 3 Sound Processor will be available in the United States in early fall. Availability in other countries is subject to regulatory approval. The Osia 3 Sound Processor has two versions, which differ only in magnet compatibility to the implant. The OSI300 Implant is compatible with the Osia 3(I) Sound Processor version. Cochlear Osia implants are MR Conditional, meaning they have demonstrated safety in the Magnetic Resonance Imaging (MRI) environment within defined conditions. Battery life varies for every user, according to the age of the battery, the programs used each day, implant type, the thickness of skin covering the implant, and the size and type of battery used. Streaming may decrease sound processor battery life depending on how often and for how long streaming is engaged. For information regarding the compatibility of Cochlear's sound processors with Apple or Android devices, visit www.cochlear.com/compatibility. Remote Assist for Osia for compatible Osia sound processors is intended for a follow-up adjustment or setup of a replacement or upgrade sound processor for suitable qualified patients based on clinical judgment. Only available at clinics that have enrolled in Remote Care. As Bluetooth LE Audio compatible devices become available, a sound processor firmware update will be required to use certain features. Auracast broadcast audio capability is subject to third party adoption of the Auracast protocol. The Osia 3 Sound Processor is designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). In clinical studies, patients with the Osia 3 Sound Processor have demonstrated improved speech understanding and preferred the sound quality over the previous generation. In clinical research, recipients said they loved the Osia 3 Sound Processor's natural, comfortable, lifelike sound – with 97% satisfied or very satisfied with its overall sound quality.決済の安定と成長配当データの取得安定した配当: OC5の配当金支払いは、過去10年間 変動性 が高かった。増加する配当: OC5の配当金は過去10年間にわたって増加しています。配当利回り対市場Cochlear 配当利回り対市場OC5 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (OC5)3.5%市場下位25% (CH)2.0%市場トップ25% (CH)3.6%業界平均 (Medical Equipment)1.1%アナリスト予想 (OC5) (最長3年)3.5%注目すべき配当: OC5の配当金 ( 3.49% ) はSwiss市場の配当金支払者の下位 25% ( 1.99% ) よりも高くなっています。高配当: OC5の配当金 ( 3.49% ) はSwiss市場の配当金支払者の上位 25% ( 3.61% ) と比較すると低いです。株主への利益配当収益カバレッジ: 現在の配当性向（ 81.5% ）では、 OC5の支払いは利益によってカバーされています。株主配当金キャッシュフローカバレッジ: OC5は高い 現金配当性向 ( 169.9% ) のため、配当金の支払いはキャッシュフローで十分にカバーされていません。高配当企業の発掘7D1Y7D1Y7D1YCH 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/14 15:51終値2026/07/14 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cochlear Limited 16 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。26 アナリスト機関Saul HadassinBarrenjoey Markets Pty LimitedStuart RobertsBell PotterElisabeth Decou CliveBernstein23 その他のアナリストを表示
お知らせ • Jul 13Cochlear Limited Announces FDA Clearance of The Osia 3 Sound ProcessorCochlear Limited received FDA clearance of the new Cochlear Osia 3 Sound Processor, the newest advancement of the Osia System. The Osia 3 Sound Processor is the first fully rechargeable active bone conduction sound processor, with up to 30 hours of battery life on a single charge. It features an on-the-go charging case that holds additional charges, similar to wireless earbuds. The Osia 3 Sound Processor offers improved clarity and sound quality, enhanced by the new signal processing platform and powerful lithium-ion battery. It now has a fitting range up to 65 dB HL bone conduction thresholds in the mid to high frequencies. The new Zaphium signal processing chip offers a wider frequency bandwidth than the previous generation and includes ForwardFocus technology, to help patients filter out the clutter of noise and focus on what matters. The Osia 3 Sound Processor joins Cochlear's industry-leading connectivity with streaming from Android, Apple, Bluetooth LE Audio and Auracast broadcast audio sources. Auracast broadcast audio allows patients to share music with a friend or tune into shared audio in places like cinemas, concert venues, lecture halls and airports, as more devices and venues adopt the technology. The Osia 3 Sound Processor is compatible with Remote Care, wireless fitting capability and improved data logging support for more convenient and intuitive fittings. With backwards compatibility, current Osia System patients who are eligible can benefit from upgrading to the Osia 3 Sound Processor no matter which Osia Implant model they have. The Osia 3 Sound Processor will be available in the United States in early fall. Availability in other countries is subject to regulatory approval. The Osia 3 Sound Processor has two versions, which differ only in magnet compatibility to the implant. The OSI300 Implant is compatible with the Osia 3(I) Sound Processor version. Cochlear Osia implants are MR Conditional, meaning they have demonstrated safety in the Magnetic Resonance Imaging (MRI) environment within defined conditions. Battery life varies for every user, according to the age of the battery, the programs used each day, implant type, the thickness of skin covering the implant, and the size and type of battery used. Streaming may decrease sound processor battery life depending on how often and for how long streaming is engaged. For information regarding the compatibility of Cochlear's sound processors with Apple or Android devices, visit www.cochlear.com/compatibility. Remote Assist for Osia for compatible Osia sound processors is intended for a follow-up adjustment or setup of a replacement or upgrade sound processor for suitable qualified patients based on clinical judgment. Only available at clinics that have enrolled in Remote Care. As Bluetooth LE Audio compatible devices become available, a sound processor firmware update will be required to use certain features. Auracast broadcast audio capability is subject to third party adoption of the Auracast protocol. The Osia 3 Sound Processor is designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). In clinical studies, patients with the Osia 3 Sound Processor have demonstrated improved speech understanding and preferred the sound quality over the previous generation. In clinical research, recipients said they loved the Osia 3 Sound Processor's natural, comfortable, lifelike sound – with 97% satisfied or very satisfied with its overall sound quality.